Colonal monomorphic epitheliotropic intestinal T-cell lymphoma with novel phenotype of cytoplasmic CD3 expression
Authors:
- Yumi AoyamaYAYumi Aoyama
- Hiroko TsunemineHTHiroko Tsunemine
- Yuriko ZushiYZYuriko Zushi
- Hayato MaruokaHMHayato Maruoka
- Yuta GotoYGYuta Goto
- Taiichi KodakaTKTaiichi Kodaka
- Tomoo ItohTITomoo Itoh
- Takayuki TakahashiTTTakayuki Takahashi
Open Access
- 1 January 2018
- journal article
- research article
- Published by Japanese Society for Lymphoreticular Tissue Research in Journal of Clinical and Experimental Hematopathology
- Vol. 58 (2) , 102-106
Abstract
Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a new clinical entity that was reclassified from enteropathy-associated T-cell lymphoma in the 2016 WHO classification. An 83-year-old man with fever and diarrhea was referred to our hospital because of free air in the abdominal cavity and wall thickening of the large intestine on CT. Colonofiberscopic examination revealed mucosal edema and multiple ulcers at the sigmoid colon, splenic flexure, and transverse colon. Histopathological examination of the mucosal biopsy specimen demonstrated dense infiltration of small lymphocytes with nuclear atypia, some of which exhibited intraepithelial invasion. Immunohistologically, these lymphocytes were positive for CD3, CD56, and perforin. Regarding CD3 expression, the antigen was found to only be expressed in the cytoplasm and not on the surface membrane on flow cytometric analysis. PCR examination of the T-cell receptor (TCR) gene revealed monoclonal gene rearrangements of TCR-γ and TCR-β. Based on these findings, a diagnosis of colonal MEITL with cyCD3 expression at Lugano clinical stage 1 was made. After conservative management of the peritonitis, we treated the patient with CHOP and DeVIC regimens, but he developed progressive disease and died. The cyCD3 expression in MEITL may be novel, suggesting a thymocyte origin of the tumor cells.Keywords
This publication has 17 references indexed in Scilit:
- Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in JapanLaboratory Investigation, 2015
- Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study GroupAmerican Journal of Hematology, 2012
- A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphomaAnnals of Diagnostic Pathology, 2011
- Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma ProjectBlood, 2011
- The light and dark sides of intestinal intraepithelial lymphocytesNature Reviews Immunology, 2011
- Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantationBlood, 2010
- Enteropathy associated T-cell lymphoma and its precursor lesionsBest Practice & Research Clinical Gastroenterology, 2010
- Intestinal Non-Hodgkin’s Lymphoma: A Multicenter Prospective Clinical Study From the German Study Group on Intestinal Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2003
- The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entitiesPathology International, 2000
- Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.Journal of Experimental Medicine, 1984